June 12, 2017

Dear Friend of TAG:

I’m so proud to share with you Treatment Action Group’s 2016 Annual Report. As you will see, TAG’s passionately dedicated, deeply informed staff have been unstinting in their efforts to speed up research and high-quality prevention, treatment, and care programs for people living with HIV, hepatitis C virus (HCV), or tuberculosis (TB), and for those most at risk of acquiring these infections. Today, more than ever, TAG’s work is vital. We are living Ending the in an unprecedented political era. Every day brings a new outrage and gathering threats to our work promoting research, prevention, and treatment. Everything TAG has fought for over the past three decades to defeat HIV/AIDS and end the TB and HCV Epidemic epidemics is at risk. Our progress towards ending these epidemics with Progress in the Fight extremely effective new tools for prevention, treatment, and cures will be in vain if people don’t have comprehensive for Better Treatment, coverage to ensure access. TAG’s vital work needs your support now more than ever: a Vaccine, and a • TAG is leading community efforts to end AIDS as an 2016 epidemic in New York State by the close of 2020 by Cure for AIDS Annual strengthening HIV, STD, and sexual health programs for Report those most affected • TAG is expanding its Ending the Epidemic work to southern states where the HIV/AIDS epidemic continues at its worst • TAG is leading efforts to build on existing law and regulation to control drug costs • TAG is leading efforts to defend key National Institutes of Health AIDS research agencies and their budgets from brutal cuts proposed by the new administration • TAG is fighting efforts to greatly weaken the U.S. Food and Drug Administration and its ability to ensure that safe and effective new drugs are studied properly, available with expanded access when necessary, and approved quickly when evidence merits it I’m pleased to report that TAG’s strong financial health and commitment to accountability and transparency have earned it a 4-star rating for the second year in a row from Charity Navigator. Charity Navigator awards only the most fiscally responsible organizations a 4-star rating. We’re so grateful to you for your dedicated support of TAG’s work, and we ask that you continue to sustain that support for the struggles ahead.

Yours truly,

Barbara Hughes President, Board of Directors were able to secure a speaker at the Democratic National Convention— Daniel D. Driffin, a young, black, gay, Project Updates HIV-positive Ph.D. student and activist. TAG expanded our federal advocacy HIV Project standing commitment to accelerate the against tuberculosis (TB), particularly for development of novel treatment options TAG’s HIV Project spent the last year TB Research & Development (TB R&D) for people living with and vulnerable to advancing its research and policy spending. Senior Health Policy Officer HIV infection. A critical extension of this priorities against a backdrop of Suraj Madoori, who joined TAG in April work—essential for strategies to end significant shifts in the federal political 2016, collaborated extensively with TAG’s AIDS and sharply curtail HIV incidence— climate and continued to push activism TB/HIV team and partner organizations is an increase in project activities that and policy aimed at effectively ending to support and set an ambitious advocacy challenge outrageously high treatment HIV as an epidemic in the U.S. – and agenda and spending targets for TB R&D costs, particularly for HIV medications ultimately, around the world. Building in the U.S. and other donor countries. priced well beyond what the market on the community-driven initiative Suraj calculated the budget shortfall from can bear, and many public and private to end AIDS in New York State, TAG is years of underfunding TB R&D, and used insurers instituting cost-control measures laying the groundwork to support and this analysis to push for new advocacy for increasingly out of alignment with strengthen community partnerships in budget appropriations in Congress and evidence-based recommendations. three southern states to chart their own among global health partners, publishing epidemic-ending strategies. two policy briefs, entitled Breathing Life TAG’s work over the past year led to the U.S. and Global Health Policy into Flatlined U.S. Government Funding publication of Community Mobilization: TAG’s Washington D.C.-based policy and for Tuberculosis Research: FY 2017–2020 An Assessment of Mechanisms and advocacy staff spent 2016, which will go Allocations and Recommendations and Barriers at Community-Based and down in history as a watershed election Breakthrough: Catalyzing R&D to End AIDS Service Organizations in Nine U.S. year in American politics, fighting for TB. These briefs were used to educate Metropolitan Areas in January 2017, favorable research, treatment access, both domestic and global community which elucidates the mechanisms, and regulatory policy and funding, which advocates and organizations, funders, facilitators, and barriers of HIV are critical in the fight against HIV, TB, and policymakers such as the U.S. community mobilization in 10 high- and HCV. Congress and the Global TB Caucus. prevalence jurisdictions. The HIV In 2016, TAG’s policy staff were At the end of 2016, several political Project completed its two-year Advocacy instrumental in launching a coalition and policy shifts posed new challenges Education Initiative, a series of online dedicated to building a national for TAG’s ongoing advocacy work. educational materials, webinars, and framework to end the epidemic in Despite a two-year-long fight led by TAG capacity-building workshops designed to the U.S. We led efforts to include a and other activists, President Obama strengthen regional advocacy and policy community-driven HIV policy and signed the hotly contested 21st Century engagement regarding comprehensive research agenda in the HIV prevention service delivery needs, Presidential candidates’ including post-exposure prophylaxis election platforms. TAG (PEP) and pre-exposure prophylaxis worked with coalition (PrEP) scale up. TAG published in partners to craft policy the Journal of the International AIDS statements and participated Society its ground-breaking primary and in meetings with both secondary HIV prevention continuum the Clinton and Sanders model for the U.S. as a conceptual campaigns, bringing framework for local health departments national attention to to identify key steps in reducing HIV coalition efforts to end the incidence and improving health epidemic. In addition to outcomes among those vulnerable to, as pressuring the campaigns well as those living with, HIV infection. to outline specific policy Left to right, NYS Senator Brad Hoylman, Board Member Joy Episalla, In tandem with these efforts, the HIV commitments to support RIAA Honoree and TAG’s Board President Barbara Hughes, and Board Project continued to uphold its long- HIV/AIDS efforts, we Member David Sigal.

2 2016 ANNUAL REPORT Cures Act into law, which contains to community-based articles and provisions that weaken the U.S. Food open-access scientific papers on and Drug Administration’s (FDA) safety the subject. standards for future drugs and devices. Using TAG’s Cure Research Media TAG successfully launched Act Now: End Monitor webpage, we responded AIDS—a national coalition dedicated to to the widely circulated claim that a organizing local networks to develop and Nigerian researcher had developed implement plans to end HIV epidemics— a cure for HIV. The BSVC Project but our momentum was challenged by alerted the Nigerian National the unexpected election results. The Health Research Ethics Committee new administration has pushed a deluge of the Federal Ministry of Health of undermining proposals to end the about the claim, contributing to Affordable Care Act (ACA); drastically the initiation of an investigation cut federal spending for research at the into what appears to have been a National Institutes of Health (NIH); curtail profoundly unethical clinical trial Rosie Perez, 2016 RIAA Honoree. public health and global health programs that was conducted without the at the Centers for Disease Control and approval of Nigerian regulators. As part and treatment. TAG worked to build and Prevention (CDC) and the U.S. Agency of TAG’s ongoing work to improve the strengthen our hepatitis C coalition; for International Development (USAID); accuracy of media coverage of HIV cure share information about advances in and severely roll back the regulatory research, the BSVC Project contacted diagnostics and treatment with advocates; capabilities of the FDA. The Independent about a misleading document research and treatment Despite the challenges and new battles headline that stated that participants in access progress and barriers; advocate that lie ahead, TAG remains committed to a research study had become “HIV free”; for sound epidemiological, biomedical, resisting major losses in research, public the editors acknowledged the problem and implementation research; and health, health care, and global health and corrected the headline. use available information to promote infrastructure, protecting these programs Richard Jefferys collaborated with policies for universal access to affordable and expanding them through increased Deputy Executive Director of HIV HCV prevention, diagnostics, care, and collaborative and cutting-edge advocacy. and HCV Programs Tim Horn and treatment, as well as the removal of The focus of our policy work in 2017 Community Engagement Coordinator structural barriers. remains unchanged as we move forward Jeremiah Johnson to develop and This year, the HCV Project successfully with our steadfast vision to end the HIV, distribute a community survey on the use recruited two dynamic new HCV Project HCV, and TB epidemics globally. of PrEP in clinical trials of biomedical co-directors, Annette Gaudino and Bryn prevention interventions. This is an Gay. Thanks to their extensive knowledge important emerging issue because and organizing experience on treatment Basic Science, Vaccines, and the efficacy of PrEP in preventing access, the HCV Project developed and Cure (BSVC) Project HIV infection raises complex ethical implemented several global campaigns to The BSVC Project organized and questions regarding how it should best address HCV elimination at the statewide, co-sponsored the annual Pre-CROI be provided to participants in clinical national, and global levels, as well as high Community HIV Cure Research trials of other biomedical prevention drug pricing, drug decriminalization, Workshop. Over 70 attendees gathered in approaches, such as vaccines. A report and harm reduction. TAG continued to Seattle to hear presentations from both describing the survey results will be confront exorbitant drug prices that act scientists and activists, and to participate released in July 2017 at the International as a major barrier to patients’ access to in discussions. The event also recognized AIDS Society Conference in Paris. direct-acting antivirals (DAAs), including and celebrated Timothy Ray Brown those that treat all genotypes. We fought reaching his tenth year since being cured through 2016 for the removal of non- of HIV infection. Hepatitis C Virus (HCV) evidence based barriers to the broadest TAG continued to regularly update its Project possible access to HCV curative therapies. listing of ongoing and completed clinical In 2016, TAG and our allies continued to TAG led local partners in advocating trials related to HIV cure research, fight locally, nationally, regionally, and for the inclusion of DAAs on the New York featured on the TAG website, as well as globally to secure universal access to State AIDS Drug Assistance Program other web-based resources, such as links affordable HCV prevention, diagnostics, (ADAP) formulary, which resulted in

2016 ANNUAL REPORT 3 Ensuring Research • updated An Activist’s Guide to TB Drugs Responds to Community to support advocacy to close research Needs and Leads to Access and access gaps; • helped launch the TB Procurement TAG’s TB/HIV project and Market-Shaping Action Team to launched its Right to Science improve TB product supply security and portfolio. In an article in affordability. TB/HIV Project Director Health and Human Rights, Erica Lessem was nominated Vice a joint submission to the Chair; UN Secretary General’s • along with the TB CAB and other High-Level Panel on Access partners, TAG called for a model list of to Medicines; Senior TB/ essential diagnostics, which the WHO HIV Project Officer Mike has now initiated efforts to establish. Frick’s plenary talk at the International AIDS Society Supporting Country-Level Access TB2016 pre-conference; and TAG supported activists in India, the Karyn Kaplan presents the 2016 Research in Action Award to the Fall TAGline edition, TAG country with the most TB cases and Daniel Lee, Executive Director of the Levi Strauss Foundation. invoked the Right to Enjoy the deaths, in holding their government Benefits of Scientific Progress, drugs from almost all manufacturers accountable for its failed TB response. articulating the responsibilities of being made available to HIV/HCV co- The #BrokenTBPromises campaign governments and companies with infected New Yorkers. TAG engaged in drove social media and press regards to TB research and access. community consultations and advocated attention through daily tweets and a The two TB-focused community for people who are most at risk and demonstration at the Union World groups that TAG supports, the Global most underserved to be involved in HCV Conference on Lung Health. In addition TB Community Advisory Board and the planning and policy-making processes, to legal victories against the government Community Research Advisors Group, particularly community forums with for failure to provide access to gave input into several clinical trial people who are HIV/HCV co-infected. medicines, this advocacy helped to drive protocols and presented on common The HCV Project shared campaign the recent announcement of national omissions at the TB2016 conference. strategies and advocacy tools with bedaquiline scale-up. To ensure ethical inclusion of partners domestically and in low- and TAG and the TB CAB called for better pregnant women, TAG drove the middle-income country settings. We global support for the TB response in establishment of a TB and Pregnancy launched the global hepCoalition Papua New Guinea, which resulted in Research Working Group, which, under website and community of practice; a monitoring mission that urged the Senior TB/HIV Project Officer Lindsay the mapCrowd data tool and summary use of new tools and paved the way for McKenna’s leadership, developed an reports with our partner, Doctors of community engagement—including observational study. the World; and developed the Pharma through a new national activist group, TAG led a coalition for the sound Greed Kills network to help mobilize Treatment Access Network PNG. development of the new TB drug activists. Recent campaigns that we sutezolid, which resulted in an open organized emphasized harm reduction Activism for TB Research Funding development license that is expected to approaches as being central to curbing The 2016 Report on Tuberculosis allow the drug’s development in optimal the HCV epidemic, and our efforts Research Funding Trends, a new regimens. included supporting the establishment cornerstone of the TB/HIV project, of supervised injection facilities and safe documented an alarming decrease consumption spaces. Creating Conditions for Access at in TB research funding. At the World the Global Level Health Organization (WHO) Global To ensure that the fruits of research are TB Symposium and the BRICS (Brazil, TB/HIV Project accessible to all, TB/HIV project staff: Russia, India, China, and South Africa) From advocating for early stage research • participated in updating global health ministers meeting, TAG and through access, TAG’s TB/HIV project guidance on drug-susceptible TB, partners called for these high-burden, work in 2016 was data driven, rights bedaquiline and delamanid, and ethics upper-middle-income countries to triple based, and especially energetic. in the TB response; research funding to fight TB.

4 2016 ANNUAL REPORT Jonathan Starch Dr. J. Michael McCune and Dr. Mrs. Florette B. Hoffheimer Timothy Gabe 2016 Richard Wolitski, PhD Karen Kaye Smith-McCune Dr. Gary L. Kaufman Leslie Asako Gladsjo Contributors Andrew D. Zacks Foundation Kenneth T. Monteiro and Leo J. Amy Kenefick Aaron Glick Blackman Babette Krolik and Harry Andre Gregory and Cindy $100,000 or more $2,500 – $4,999 George and Mirla Morrison Greenwald Kleine Bill & Melinda Gates Foundation AIDS Fonds Netherlands Laura A. Morrison Kate B. Lear and Dr. Jonathan DJ Hanson Gilead Sciences Amida Care/Doug Wirth, Sally Morrison and Toby Corser LaPook Chris Harrington and Daphne Elton John AIDS Foundation President & CEO New Ground Fund of Marin Jay Leitz Powell Open Society Foundations Benjamin, Christine, and Community Foundation: David C. Levine Larry Iannotti “in honor of Veterans Affairs Medical Darius Anagnos Arianne Z. Dar Joseph McConnell and Erik Richard Lynn” Center of Washington, D.C. Celeste B. Cooper NYC Department of Health Haagensen John Kander and Albert ViiV Healthcare Richard D. Dadey and Mental Hygiene, Bureau Médecins du Monde Stephenson M. Lee Garrison “in Honor of of HIV/AIDS Prevention and Albert S. Messina and Ken Cynthia Kaplan Control Jennings $50,000 – $99,999 Alby Maccarone” Charles S. Laven Jason Osher and Richard Scott W. Morgan and Fred Ford Foundation Mitchell Gold + Bob Williams Burt R. Lazarin Schubel Hersch Janssen Therapeutics Housing Works / Charles King Lim Leigh Walter Rieman “in Memory of NASTAD / Murray C. Penner Levi Strauss Foundation & Matthew Bernardo Linda Liedtka Tom Stoddard” Mitchell Netburn “in honor of Stanton J. Lovenworth M•A•C AIDS Fund Dr. Bruce R. Schackman and James Saakvitne Barbara Hughes” Dr. Merle C. McCann “in Edward K. Sikov Andrew C. Schirrmeister III Donna M. Pauldine “in memory memory of John Stuban” $25,000 – $49,999 W. Kirk Wallace and Mark Evan Schwartz and Robert of Jeff Palladino” Elaine and Glenn Mealy Bristol-Myers Squibb M. Sexton Fund of the Fitterman David Pavese and Virun Mark W. Melchior Broadway Cares/Equity Fights Stonewall Community George P. Sheer and Matthew Rampersad Jeff Mendoza AIDS Foundation D. Warnecke Eddie Pelto Scott Newman Stony Wold-Herbert Fund Virginia Shubert and David Linwood and Frank Potter- Ann Northrop Stop TB Partnership $1,000 – $2,499 Sipress Gainey / Bangz Hair Salon Pam A. Parker Joy A. Tomchin Charitable Fund ACRIA / Benjamin Bashein Audrey L. Sokoloff and Timothy & Spa Diane Parrish Stanley H. Tomchin Charitable Jim Aquino Hosking Daniel Ptacek Donna L. Peck “in honor of Fund Katherine C. and Thomas M. Peter Staley Dr. Robert Remien Robert Monteleone” Ash III Morton Steinberg David Richwine B. Pelton $10,000 – $24,999 Ashfield Healthcare Monte Steinman Diane Robina Pamela Perkins amfAR, The Foundation for Communications Tiger Tail Family Foundation: Margaret Russell Jim Pickett “in honor of Tim AIDS Research AVAC / Mitchell Warren Valerie Brown William Russell Horn” Debs Foundation: Richard A. Frank Bua and Scott Carroll Donn Vecchie-Campbell Jane Silver Clifford Richner “in honor of and Barbara Knowles Debs; John V. Calcagno and Dr. Amr John Voelcker Ali Soucy Dick Dadey” Nick Debs Abdelaziz James M. & Ruth E. Wilder Dr. Jack Steever Gregory ‘Greig’ Sargeant Genentech John Caldwell and Zane Foundation: Terri Wilder Keith S. Tobin, MD Merrie Shinder Annie Bennett Glenn Fund “in Blaney Queer Legacy Fund P. Forrest Williams Jr. Paula Silver honor of P. Forrest Williams” of Horizons Foundation $500 – $999 Sue Simon Kevin and Neil Goetz Scott P. Campbell Lydia Ashcroft “in honor of $250 – $499 Alexander Smith INPUD, the International James F. Capalino / Barbara Hughes” Peter Allen “in honor of Bruce Vicente Wolfe “in honor of Network of People Who Use Capalino+Company Judith D. Auerbach Schackman” Margaret Russell” Drugs Capital Group / Jameel Jiwani A. Cornelius Baker Anonymous Merck & Co. and Aditya Sankaranarayan Michael Beltran and Tim Ford Ivy Arce “in honor of Richard Plus donations from an The New York Community Trust Dr. and Mrs. Charles C.J. Bob Bronzo Jefferys, Tim Horn, Lei additional 338 contributors The Elizabeth Taylor AIDS Carpenter Steven Capone Chou, Annette Gaudino, and as well as support from the Foundation Mary and Timothy Casey Paula and Mitchell Chalfin Jeremiah Johnson” United Way TB Alliance Kenneth D. Cole and Maria Denise and Steven J. Chickery Mark Aurigemma World Health Organization Cuomo Cole Christie’s / Amelia Jonathan Bank We would also like to thank BC Craig and Ruth Finkelstein Manderscheid Alvin H. Baum Jr. the following for their $5,000 – $9,999 Drake/Anderson Stephanie Cowles Amy and Peter Blauzvern “in generous in-kind donations of Anonymous via Jewish John F. Duane Richard J. Davis and Nancy honor of Monte Steinman” services and goods: Communal Fund Charles Franchino R. Davis Frank and Meredith Bove Blueprint NYC David Corkery Gendal Family Charitable S. David Deitcher Rachel Bozich Rosalind Fox Solomon Addie Guttag / AJG Foundation Foundation John Deyling Karen Bronzo and Jefferson SPOTCO Harvard University Global Health Strategies / Paul L. Dietz Rabb Barbara Hughes David Gold Peter Morris Dixon Howard Brown Health Center as well as the following Robert Lennon and Mark Gilrain Judith and Steven Gluckstern Michelle and Andre Dore / The Louis Brown “in honor of donors of items for TAG’s Richard M. Lynn and Joseph GMHC / Kelsey Louie InkLink Group “in honor of Monte Steinman” Silent Auction: Evall Dr. Roy M. “Trip” Gulick TAG” Richard Cardillo “in memory of Almond Restaurant Alby P. Maccarone Jr. Alexa Hampton Joy Episalla and Carrie Peter F. Diffly Jr.” Billy Bean/Major League Robert J. McLain and Alberto Mark Harrington “in honor of Yamaoka Jeanie Carstensen Baseball Blanquel Barbara Hughes” Steven M. Frank and Dr. Kenneth Castro Bow Tie Cinemas Robert Monteleone Richard and Judith M. Elizabeth S. Powell Centers for Disease Control Equinox Partners In Health Harrington Gayle and William French “in and Prevention Mitchell Gold + Bob Williams Prochilo Health Karen and Stephen D. Hirdt memory of Jay Kevin Funk” Nancy Clayman Fred Hersch David Rosenauer and Rex IAVI / Mark Feinberg, MD, PhD Howard A. Froman and R. Scott Scott Dainton Kiehl’s Since 1851 Walker Fund of Liberty Hill JPMorgan Chase & Co. Briggs Lynda M. Dee KleinReid Porcelain Gallery Foundation Martin L. and Beth M. Katz NYS Assemblymember Joseph and Mary Ann London West Hollywood Hotel Sigal Family Foundation: Karolyn E. Kovarik Deborah J. Glick DiNorcia “in honor of Jason Fernando Juan Alva Mirás Gerald R. and Ellen V. Sigal, Peter Kukielski and J. Drew Ron Goldberg and Joe Chiplock Osher” Osteria Morini David Sigal, New York State Hodges Paula Hartstein and Jonathan Mario Egozi NBC Universal “Late Night Senator Brad Hoylman, and Winston B. Layne Levin “in honor of Erica Dean Eisner with Seth Meyers” Sylvia Hoylman-Sigal Michael K. Longacre Lessem” Carol and John Field Fund Stuart Thompson Productions

2016 ANNUAL REPORT 5 TAG Financials Balance Sheet 2016 2015* Assets Cash and cash equivalents $ 1,978,688 $ 2,971,378 Contributions receivable 73,871 171,984 Prepaid expenses and other current assets 31,826 24,928 Donated artwork 404,500 381,000 Security deposits 72,463 43,015 Property and equipment — net 30,870 17,666 Total Assets $ 2,592,218 $ 3,609,971 Liabilities and Net Assets Liabilities Accounts payable and accrued expenses $ 74,083 $ 20,734 Net assets Unrestricted 1,355,999 1,649,386 Temporarily restricted 1,162,136 1,939,851 Total net assets 2,518,135 3,589,237

Total Liabilities and Net Assets $ 2,592,218 $ 3,609,971

* FY15 Assets reflect a $1,070,138 pre-payment from the Bill and Melinda Gates Foundation for program expenditures in FY16 and the first quarter of FY17.

Statement of Cash Flows 2016 2015 Cash Flows From Operating Activities Change in net assets $ (1,071,102) $ (191,480) Adjustments to reconcile change in net assets to net cash provided (used) by operating activities Depreciation 7,246 8,464 Donated artwork (23,500) (38,500) Loss on disposal of fixed assets 4,745 3,166 Decrease (increase) in assets Contributions receivable 98,113 1,991,131 Prepaid expenses and other current assets (6,898) (797) Security deposits (29,448) Increase (decrease) in liabilities Accounts payable and accrued expenses 53,349 (9,789) Net cash provided (used) by operating activities (967,495) 1,762,195 Cash flows from investing activities Purchases of fixed assets (25,195) (3,782) Net change in cash and cash equivalents (992,690) 1,758,413 Cash and cash equivalents — beginning of year 2,971,378 1,212,965

Cash and cash equivalents — end of year $ 1,978,688 $ 2,971,378

6 2016 ANNUAL REPORT Statement of Activities 2016 Temporarily Unrestricted Total Restricted Revenues and Other Support Contributions and grants $ 334,641 $ 1,055,972 $ 1,390,613 Special events income $ 294,745 Less direct costs of special events (91,952) 202,793 202,793 Other income 28,381 28,381 Interest income 1,885 1,885 Net assets released from restrictions 1,833,687 (1,833,687) Total Revenues and Other Support 2,401,387 (777,715) 1,623,672

Expenses Program services HIV Project 508,856 508,856 Cure Project 144,777 144,777 Hepatitis C Virus Project 345,198 345,198 TB/HIV Project 1,155,069 1,155,069 U.S. and Global Health Policy Project 15,404 15,404 Total program services 2,169,304 2,169,304 Supporting services Management and general 304,774 304,774 Fund raising 215,951 215,951 Total Supporting Services 520,725 520,725

Total Operating Expenses 2,690,029 2,690,029

Change in net assets before loss on disposal of fixed assets (288,642) (777,715) (1,066,357) Loss on disposal of fixed assets (4,745) (4,745) Change in net assets (293,387) (777,715) (1,071,102) Net assets — beginning of year 1,649,386 1,939,851 3,589,237

Net Assets — End of Year $ 1,355,999 $ 1,162,136 $ 2,518,135

See independent auditor’s report. The accompanying notes are an integral part of these statements.

Summary of 2016 Functional Expenses 11% Management and Administration 8% Fundraising

Program Services 81%

2016 ANNUAL REPORT 7 TAG Limited Art Editions BOARD OF DIRECTORS Each year at its annual Research in Action Awards, TAG presents a new, PRESIDENT Barbara Hughes limited edition work of art, generously donated by a highly regarded visual SECRETARY AND TREASURER Laura Morrison artist. Past artists include Joy Episalla, Kate Shepherd, Nan Goldin, Robert Jim Aquino Frank Bua Gober, Bill Jacobson, Donald Moffett, Dick Dadey Tony Feher, Carrie Yamaoka, and Nick Debs David Armstrong. Joy Episalla TAG retains an inventory of many Kevin Goetz of the editions for sale to the public. Roy Gulick, MD All proceeds benefit TAG in support of Robert W. Lennon Richard Lynn, PhD programmatic work. Alby Maccarone If you are interested in purchasing Robert Monteleone an edition or learning more about Jason Osher the available editions, detailed David Sigal information can be found at http:// Monte Steinman www.treatmentactiongroup.org/ EXECUTIVE DIRECTOR limited-art-editions. About TAG Mark Harrington Treatment Action Group (TAG) is an DIRECTOR OF POLICY AND ADVOCACY Contribute independent, activist and community- Kenyon Farrow TAG welcomes donations from individuals based research and policy think tank SENIOR TB/HIV PROJECT OFFICER who want to see the research agenda fighting for better treatment, prevention, Mike Frick remain responsive to the needs of all a vaccine, and a cure for HIV, tuberculosis, HCV PROJECT CO-DIRECTOR people living with HIV, HCV, and TB. and hepatitis C virus. Annette Gaudino Make a tax-deductible gift now: TAG works to ensure that all people HCV PROJECT CO-DIRECTOR www.treatmentactiongroup.org/support. with HIV, TB, or HCV receive lifesaving Bryn Gay Does your company have a matching treatment, care, and information. DEPUTY EXECUTIVE DIRECTOR OF HIV gifts program? If so, you can double or We are science-based treatment AND HCV PROGRAMS even triple your donation. Just complete activists working to expand and Tim Horn the program’s matching gift form and accelerate vital research and effective BASIC SCIENCE, VACCINES, AND CURE send it in with your donation to TAG. community engagement with research PROJECT DIRECTOR When you shop on Amazon, enter and policy institutions. Richard Jefferys the site at smile.amazon.com. Choose TAG catalyzes open collective action by COMMUNITY ENGAGEMENT TAG Treatment Action Group as your all affected communities, scientists, and COORDINATOR Jeremiah Johnson designated charity, and 0.5 percent of policy makers to end HIV, TB, and HCV. the price of your eligible purchase will TB/HIV PROJECT DIRECTOR Erica Lessem benefit TAG. SENIOR HEALTH POLICY OFFICER Suraj Madoori 90 Broad Street, Suite 2503 ADMINISTRATOR Save the Date! Joseph McConnell November 16th, 2017 at 6:00 pm New York, NY 10004 Tel 212.253.7922 SENIOR TB/HIV PROJECT OFFICER Research in Action Awards Lindsay McKenna Celebrating TAG’s 25th Anniversary Fax 212.253.7923 [email protected] DEPUTY EXECUTIVE DIRECTOR OF www.treatmentactiongroup.org OPERATIONS Scott Morgan TAG is a nonprofit, tax-exempt 501(c)(3) organization. FINANCE MANAGER David Zwany EIN 13-3624785

8 2016 ANNUAL REPORT